4EM-13477-00289
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 801 / CO
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- VNC-64341-76570
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-02-24
Dose 1 — Pfizer-BioNTech
-
2022-03-24
Dose 2 — Pfizer-BioNTech
-
2022-06-27
Registered in v-safe
- 2022-06-27
-
2022-09-22
Survey response — 6 months, dose 2, dependentMedDRA: Hypersensitivity, Pre-existing disease — Feeling: GoodFree text: Severe seasonal AllergiesMedDRA releases: 2024-11 · check-in free text available
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-02-24 | Pfizer-BioNTech | No |
| 2 | 2022-03-24 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 2, dependent
Symptoms: Severe seasonal Allergies
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release